PHVS Competitors & Alternatives
Compare Pharvaris BV with similar stocks in the same industry
Biotechnology
PHVS
Main Stock$36.27
Tradestie Score
44
Market Cap
$1.55B
Analyst Upside
+34.6%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CPRX
Catalyst Pharmaceutical Inc.
|
$31.49
|
$2.56B | 18.2 | 51 | Compare |
|
CDTX
Cidara Therapeutics, Inc.
|
$221.38
|
$2.44B | - | 50 | Compare |
|
BEAM
Beam Therapeutics Inc. Common Stock
|
$29.76
|
$2.44B | - | 42 | Compare |
|
TARS
Tarsus Pharmaceuticals, Inc. Common Stock
|
$72.70
|
$2.42B | - | 33 | Compare |
|
BLTE
Belite Bio, Inc American Depositary Shares
|
$161.06
|
$2.41B | - | 53 | Compare |
|
IDYA
IDEAYA Biosciences, Inc. Common Stock
|
$39.67
|
$2.40B | - | 43 | Compare |
|
FOLD
Amicus Therapeutics, Inc
|
$14.49
|
$2.38B | - | 52 | Compare |
|
ARQT
Arcutis Biotherapeutics, Inc. Common Stock
|
$25.08
|
$2.37B | 120.7 | 58 | Compare |
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$134.75
|
$2.35B | - | 56 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$7.79
|
$2.34B | - | 43 | Compare |
More PHVS Analysis
Data updated: Aug 23, 2026 | Industry: Biotechnology (SIC 2834)
236 stocks in this industry